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1. Introduction 
Immunofluorescence microscopy is a powerful tool for the detection of multiple changes in 
single cells at sub-cellular level. During the last 10-15 years, confocal and wide-field 
microscopy have evolved from tedious small scale experiments to medium- or even high-
throughput technologies, under the name of high-content screening (HCS). Sample 
preparation and image acquisition have been automated and several software applications 
are available for image analysis to obtain quantitative information from the cells. In 
academia HCS is mainly used in siRNA and cDNA screens to identify genes and proteins 
involved in specific pathways and processes (Blackmore et al., 2010; Neumann et al., 2010; 
Pelkmans et al., 2005 as examples). siRNA screens are performed also in pharmaceutical 
companies for target identification. In addition, in pharmaceutical industry HCS has been 
adopted as an enabling technology for compound profiling, compound development, 
secondary screening and even full-deck primary screening (Guzi et al., 2011; Ibig-Rehm et 
al., 2011; Li et al., 2003; Nadanaciva et al., 2011; Simonen & Gabriel, 2008). The field is still 
rapidly evolving and new automated cell imagers are coming to the market as well as novel 
software for image analysis. HCS provides vast amounts of data from each sample and even 
from each individual cell. During the last years various programs to analyze this data in a 
multiparametric way have been developed (Gorenstein et al., 2010; Kümmel et al., 2011, 
Neumann et al., 2010). 
Below, the benefits of HCS technology for primary hit finding and secondary screening 
experiments are discussed. In addition, the technical requirements for high- and medium 
throughput, the challenges in plate preparation and imaging, image and data analysis and 
data management are outlined. Examples are provided how to use HCS in primary hit 
finding campaigns, as well as its use in sophisticated lower-throughput assays using 
primary cells to generate added value.  
2. What are the benefits of high-content screening 
Biochemical screens for drug candidates utilize purified proteins in very reductionist assays 
with the benefit that the compounds can act directly on the target. However, some proteins 
may not be purified being in their native conformation, sometimes only the catalytic domain 
of the protein is used in the assay due to problems of producing the full-length protein, and 
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the substrates are often artificial. When a protein functions in a multiprotein complex it 
might be difficult or impossible to produce all the subunits and to assemble them in an 
active complex. Sometimes all the components contributing to a cellular reaction are not 
even known. Typically biochemical screens are performed to identify inhibitors of kinases, 
proteases, enzymes and protein-protein interactions. 
In cellular assays exploiting genetically non-manipulated cells all the components needed 
for a reaction are usually present, properly assembled and in physiologically correct 
stoichiometric relations. However, in cellular screens marker or reporter constructs are often 
used in cells over-expressing the target. In reporter gene assays (RGAs) the readout is 
usually indirect and can be far downstream of the actual target. Often reporter genes are not 
in their natural environment in the genome, and they may contain incomplete regulatory 
regions. Therefore, RGAs are prone to pick up unspecific compounds. Other cellular 
screening formats for G protein-coupled receptors (GPCRs) like Ca2+ flux assays, 
homogeneous ELISA assays, bioluminescence resonance energy transfer (BRET) and the 
numerous luminescence-based assays for cell viability and toxicity are robust, easy and fast 
to perform. Nevertheless, they provide information about a single parameter only, whereas 
sub-cellular imaging is able to deliver more content. Multiple parameters like cytoplasm 
shape, size, area, as well as information about nuclear intensity, size, and shape in addition 
to the target-specific fluorescence readouts can deliver various insights of the compound’s 
mode of action and unspecific effects early on.   
In addition to increased content, another benefit of HCS is to enable screening with assays 
that were earlier impossible in high throughput, such as trafficking of proteins within cells 
or morphological changes. Sophisticated image analysis in HCS provides more information 
from the hits than the traditional screens, cytotoxicity being only one additional feature 
obtained in HCS assays. HCS enables screening for pathways and phenomena without 
having a specific target in mind, thereby allowing identification of novel targets. Typical 
examples of phenotypic screens are stimulation of neurite outgrowth, neuronal survival, 
autophagy or muscle growth. As in standard cellular screens, also in HCS often genetically 
manipulated cells are used, but HCS assays can be performed with non-manipulated or 
primary cells by analyzing changes in endogenously expressed cellular components, which 
makes the assays physiologically more relevant. Compared to traditional biochemical and 
cellular screening assays HCS is still slower and usually non-homogeneous. Washing steps 
are generally required in the staining process and image acquisition takes longer than 
reading fluorescence or luminescence with plate readers, making HCS more time-
consuming and expensive.  
We have compared variability and sensitivity of HCS and RGA for the screening of 
inhibitors for PI3K – Akt – Foxo3A pathway. Both assays were equally reproducible, but the 
HCS assay had a better statistical quality. The HCS assay was more sensitive than the RGA 
although it was not able to identify additional chemical scaffolds as hits (Unterreiner et al., 
2009). However, this study represents only one HCS assay and one RGA, and the picture 
might change when comparing more assays. 
Since 2005 we have used HCS in primary and secondary screening in numerous projects 
with varying biology and assay set up. Being convinced about the power of HCS we have 
recently started to perform also full-deck (>1 million compounds) primary screening with 
the HCS technology. 
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3. Technical aspects of HCS  
3.1 Cells 
Not all cells are equally suited for HCS due to the requirements of microscopic images and 
image analysis. Large cells, not clumping or growing on top of each other are best suited for 
automated image analysis. The U-2 OS osteosarcoma cells are an example of a cell line well 
suited for automated image analysis: The nuclei are well separated from each other allowing 
determination of the accurate cell number, and the cytoplasm of U-2 OS cells is large 
enabling sub-cellular image analysis (Fig. 1). HEK293 cells, derived from human embryonic 
kidney cells, are commonly used in cell biology and in cellular screening, but due to their 
small size they are less suited for sub-cellular analysis. In small-scale experiments high-
resolution objectives might be used, therefore the size of the cells does not limit the 
experiments as much as in higher throughput assays.  
 
 
Fig. 1. Examples of some commonly used cell lines with different suitability for HCS. All 
images are in the same scale and were acquired with IN Cell Analyzer 3000 using the 40x 
objective. The upper panel images show nuclei stained with different dyes: U-2 OS, red: 
DRAQ5; HEK293 and HepG2, blue: Hoechst 33342. In the lower panel overlay images are 
shown using the respective nuclear stain and U-2 OS, green: GFP fusion to a cytoplasmic 
protein; HEK293, green: cytoplasmic/nuclear protein stained with an antibody; and HepG2, 
pink: surface receptor stained with an antibody. 
For automated image analysis, the cells need to be well separated in order to normalize the 
signal to cell number to account for changes in cell density by batch to batch variation. Some 
cells, such as the commonly used hepatocellular carcinoma HepG2 cells, are clumping and it 
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is difficult to determine the cell number based on the nuclear stain. In addition, the HepG2 
cells are small in size (Fig. 1). Suspension cells are also not well suited for HCS due to the 
potential loss of cells by the washing steps of staining processes. In addition, suspension 
cells are small allowing measurement of changes in fluorescence intensity but analysis of 
any sub-cellular compartment is hardly feasible. However, depending on the biology, we 
have used sometimes also small, clumping and even suspension cells in HCS. In these cases 
the available readouts in image analysis were limited, but by evaluating different methods 
to stain the cells and to analyze the images acceptable and satisfactory results could be 
achieved. 
Not only established or recombinant cell lines, but also primary cells, as well as embryonic 
and induced pluripotent stem cells can be used in HCS assays. The benefit of using 
genetically non-manipulated cells is that the relevant components of the pathway studied 
are expressed endogenously at proper expression levels and regulated in an authentic way. 
Fusion of the target to a fluorescent protein, however, is very convenient in HCS assays, 
since antibody staining can be omitted. Very often transiently or stably transfected cells are 
used, whereby the expression and regulation of the fusion protein is at least partly under the 
control of non-natural elements. Creating knock-in cells, where the fusion protein or the 
marker is in the natural position in the genome most closely mirrors the endogenous 
expression and regulation. Generation of cells with disease-relevant mutations with this 
technique provides excellent cell models for screening (Nilles & London, 2007). Until now 
most of the cells generated with this approach are either cancer cell lines or of mouse origin. 
However, the technology for induced pluripotent cells is advancing rapidly, making 
differentiated human cells with natural disease-relevant mutations available (Park et al., 
2008). 
3.1.1 Live cell analysis versus fixed cells 
For kinetic studies living cells are obviously needed. Several large time-lapse high-content 
screens have been performed in academia. Such screens provide an advantage when 
processes like apoptosis, where the cells are responding non-synchronously, are studied 
(Antczak et al., 2009). Also mitosis, which is a rare event at any given time in a cell 
population, benefits from a time-lapse analysis (Neumann et al., 2010; Schmitz et al., 2010). 
To follow live cells over time, either fluorescent proteins are used as markers or the cells are 
stained with dyes that are tolerated by the cells. In order to analyze all samples with the 
same time intervals good logistics in sample preparation and imaging is required. The 
different steps in the whole screening process (cell culture and plating, transfection or 
compound addition, cell incubation and image acquisition) need to function seamlessly 
which results in reduced batch sizes in live cell screens. 
Cell fixation after compound or siRNA treatment enables decoupling sample preparation 
and image acquisition. Thereby these two processes do not need to function synchronously, 
and the fixed plates can be stored at 4°C relatively long times (3-5 days generally, depending 
on the assay also >5 days) without loss of fluorescence signal. Using assays with fixed cells 
allows higher throughput at a defined end point. However, such assays provide information 
on the effect of the analyzed compounds only at a single time point that needs to be 
carefully evaluated for the screen. We have chosen to fix the cells in our screening 
campaigns, since this allows us more flexibility in the use of the imagers and the plate 
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preparation platforms and an increase of batch size. Also, in case of a technical problems, 
samples are not lost, and can be imaged after solving the technical issues. 
3.2 Sample preparation - automation 
HCS assays using fixed cells are non-homogeneous with the need of several washing steps, 
with the number of washing steps depending on the use of fluorescent fusion proteins or 
antibody labelling. In our screening unit, the vast majority of projects use antibody staining 
to visualize the target proteins rather than fluorescent fusion proteins. Therefore, we have 
built automated platforms for fixation, staining and washing steps required by 
immunostaining protocols. The first platform (Fig. 2A) serves for compound addition to cell 
plates followed by an incubation step at 37°C for a defined compound incubation time. 
Thereafter the cells are fixed by e.g. addition of paraformaldehyde using a dispenser, 
followed by a washing step with a 1536-well plate washer. On the second platform (Fig. 2B) 
the plates are further processed by dispense of primary and secondary antibodies, followed 
by incubation and washing steps. In order to gain flexibility compound addition and 
fixation steps are decoupled from the antibody staining process on separate platforms. 
 
 
Fig. 2. Plate preparation platforms for automated HCS assays in 384 and 1536-well formats. 
A) Platform is used for compound addition, incubation and fixation. B) Platform is 
equipped with robot, dispensers, washers and incubators for automated antibody staining. 
When setting up a 1536-well plate high-content assay with an automated plate preparation 
platform it is critical to test the accuracy (correctness of the transferred volume) and 
precision (reproducibility) of the plate washers and dispensers, since they have a very high 
impact on the quality of the HCS assay. Especially for 1536-well dispensers and washers the 
maintenance and washing procedures are critical to avoid clogging of the pins. The time 
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needed for plate preparation of an immunostaining assay is much longer than in 
homogenous assays and the higher number of steps can introduce more errors.  Therefore, 
due to the increase of protocol complexity unattended runs are more challenging.  
3.3 Cell imagers 
In brief, cell imagers for high-content screening are automated microscopes with automated 
image analysis. The first automated cell imager came to the market 1997 (Giuliano et al., 
1997). Since then, numerous confocal and wide-field imagers have become commercially 
available. Many of them are, or can be optionally equipped with environmental control for 
live-cell assays. The instruments are usually equipped with autofocus and an image analysis 
software is included in the package. 
For small and medium-scale experiments the throughput of the instrument is not as crucial; 
however, for high-throughput screening the following features are important: a) the imager 
should accept 1536-well plates, b) the speed of image acquisition should be high (20-90 min 
per 1536 well plate), and c) the hard disk of the instrument should be able to store terabytes 
of data, or alternatively setup for automated data transfer to a dedicated server.  
Imaging speed can be enhanced by acquiring two or even three images on different channels 
simultaneously. This is possible by using imagers equipped with several cameras. However, 
due to overlapping emission spectra it is rarely possible to acquire more than two images 
simultaneously. To achieve reasonable statistics, a certain amount of cells need to be 
analyzed per treatment or well. This can be achieved by acquiring several images per well 
which, however, will prolong the imaging process. An improvement is the use of cameras 
with large field of view to capture a decent number of cells in each single image.  
Depending on the assay and throughput, different imagers are optimal for high-content 
screening. In our unit we have used four different HCS instruments. We started HCS using 
IN Cell Analyzer 3000 (GE) which is a high-resolution confocal imager equipped with 3 
laser lines, 3 CCD cameras with a large field of view and on-the-fly image analysis 
(simultaneous with image acquisition). It is a fast instrument with user-friendly image 
analysis software, although unable to read 1536-well plates. In order to perform full-deck 
HCS campaigns in 1536-well format we setup the Opera QEHS (PerkinElmer) which is a 
confocal imager equipped with 4 lasers and 4 CCD cameras allowing on-the-fly image 
analysis with sub-cellular resolution. Thus, Opera is the imager of choice for higher 
throughput screening campaigns with the need of high resolution.  For HCS with medium 
throughput we use IN Cell Analyzer 2000 (GE) which is wide-field imager equipped with a 
large-chip CCD camera. It can handle 96-1536 well plates; however, image analysis needs to 
be done after image acquisition. For high-throughput screening campaigns requiring for 
example fluorescence intensity measurements without sub-cellular resolution, we utilize the 
Acumen® eX3 (TTP LabTech), a plate scanning device equipped with three lasers. Also 
Acumen allows analysis of the distribution of fluorescence intensity on-the-fly (in parallel to 
scanning). In chapter 4 we give examples of different screening campaigns and devices 
chosen for different assays. 
3.4 Image analysis 
To efficiently use the wealth of information within the acquired images the automated 
microscopes are delivered with image analysis software. In addition, several commercially 
and freely available third party software packages are available to analyze microscope 
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images (Carpenter et al., 2006; Gilbert et al., 2009¸ Rämö et al, 2009; Wang et al., 2010). The 
image analysis programs vary from simple, easy-to-use ready-made modules to writing the 
image analysis scripts by the user (Niederlein et al., 2009; Pepperkok et al., 2006¸ Swedlow et 
al., 2003). The former ones make the start of HCS easier for beginners, but the latter offer 
more flexibility in terms of excluding unwanted structures or defining specific cellular 
compartments.  
For automated image analysis good quality images are required. By size exclusion, dust or 
larger particles can be filtered out as well as fluorescent particles by fluorescence intensity 
filter. Sub-cellular analysis is often shown in literature for a single cell as example. When 
transferred to all cells from a whole well or even to all wells of a 1536-well plate, the 
algorithm needs to be stable to account for cell populations where size or orientation of the 
cells may vary. In addition the analysis scripts need to be robust since the intensity of the 
staining of the cells can vary from well to well due to pipetting procedures.  
From a technical point of view, the simplest solution is to use the image analysis software of 
the imager since no transfer of the images or image conversion step is required. The fastest 
solution is to analyze images in parallel with image acquisition (on-the-fly image analysis). 
On-the-fly analysis offers the additional advantage by monitoring the assay quality in a 
timely fashion that in case of a decreased assay quality, the screener can interact 
accordingly. Being able to perform image analysis with a computer cluster instead of 
individual computer(s) would be of great benefit for high-throughput screens to improve 
analysis speed. Another way to accelerate image analysis is to use multicore computers that 
can analyze several wells in parallel. However, not all image analysis software packages 
support multicore analysis. 
Not only the provided software coming with the instrument, but also third party software 
can be used for image analysis. However, each imager creates usually a specific image 
format with link to metadata (like objective lens used, pixel resolution etc.) which can 
complicate the use of third party analysis software. Conversion of the images to another 
format is often required which slows down the whole screening process and usually 
increases the space needed for image storage. We routinely use the image analysis software 
provided with the imager, especially for high-throughput campaigns. In few exceptional 
cases requiring specific algorithms, a third party software with specific features is used for 
small or medium scale screens. 
3.5 Data analysis 
To analyse single readouts from HCS campaigns any high-throughput data analysis tool can 
be used which is able to display heatmaps for plate pattern analysis and to perform dose 
response curve fitting. The unique requirement for image-based HTS is the generation of a 
link to the images to rapidly verify whether a hit is a true active or a false positive (Fig. 3). 
Preferentially the visualization is established in a software package where treatment or 
compound information is linked.  
HCS is able to provide information-rich data sets containing readouts on multiple cellular 
parameters. In addition to the fluorescence intensity parameters and number of cells, their 
morphology and the intracellular distribution of cellular proteins can be analysed 
quantitatively (Loo et al., 2007; Young et al., 2008). To explore the high content of images 
through multi-parametric data analysis more sophisticated tools are needed. The 
combination of several parameters can improve the assay quality, however, the statistical 
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parameter, Z’ value, which is commonly used for single readouts needs to be adapted for 
the analysis of multiple features (Kümmel et al., 2010). 
 
 
Fig. 3. Example of a concentration response curve fitted in the program to analyze screening 
data. By clicking an analysis point in a concentration response curve or a well in a heatmap, 
the respective image is displayed. 
In order to enable the analysis of dozens of features in parallel we have generated an in-
house software package (Kümmel et al, 2011). Multiple readouts can be either combined to 
classify samples into hits or inactives or to cluster sample responses into groups similar to 
control compounds or samples with similar phenotypes (Fig. 4). Such clustering analysis can 
be used in primary screening for hit identification as well as to cluster hits based on their 
potency, toxicity or off-target effects. 
 
 
Fig. 4. Analysis of multiparametric HCS data. Data preprocessing consists of correction for 
plate pattern and plate effects, parameter selection by dimension reduction and well 
summary. The parameters are being further analyzed by either classification or clustering. 
Visualization of clustering results in self-organizing maps helps to identify similar 
phenotypes.   
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3.6 Data management  
Every imager generates its own sometimes proprietary image format, and the format of the 
data files from each image analysis differs depending on the analysis software used. 
Therefore, data management and data mining can be problematic when using different 
imagers or image analysis software packages. With certain image analysis software the data 
output format might even vary depending on the analysis algorithm applied. To enable the 
link from image and metadata to the result file can be a challenge due to the variety of 
formats. In addition, creating software tools enabling the search of plates, compounds, or 
treatments combined with image and data visualization for comparison of images and data 
generated by different imagers is still a major challenge. 
The high-throughput screening with sub-cellular resolution is focused to specific sites in our 
company with the consequence of interacting with project teams located in different 
countries. To allow all team members to view the images irrespective whether they have the 
specific analysis software or not, we have created a web-based tool to display the images 
(Fig. 5). 
 
 
Fig. 5. Visualization of cell images with a web-based tool. Individual wells inspection (A) 
and whole plate views (B) are possible. In addition images from the respective well or plate 
view can be explored with higher magnification to visualize details (C). 
With this tool individual images as well as an overview of all images on the plate can be 
visualized, however no analyzed data is being displayed.  Currently we are implementing a 
database where all images and result files are being stored. The visualization in form of 
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heatmaps will be available for different readouts enabling the comparison of the quality of 
the respective readouts. A direct link from the heatmap will open the image to check the 
integrity of the well for a quick verification of the results.  
 
 
Fig. 6. Visualization of the respective readouts with a link to the images.  
4. HCS in primary high-throughput screening 
The technologies that have enabled high-content screening in high throughput include plate 
washers and dispensers for 1536-well plates as well as robot-friendly 1536-well plates 
suitable for imaging using 10x objectives. Decoupling the plate preparation and imaging 
processes allows us to exploit all HTS platforms optimally and thereby increase the 
throughput.   
Since we have different instruments in our HCS platform we usually compare image and 
assay quality and throughput for each project on different readers, and choose the 
instrument based on the highest quality and throughput. Example projects are described 
covering high-throughput and medium-throughput campaigns as well as projects with 
different requirements for resolution.  
4.1 HTS for inducers of protein aggregation 
As an example, a high-content screening campaign in high throughput to identify 
compounds inducing protein aggregation within the cytoplasm is described. The sub-
cellular analysis of individual cells provided reliable results that could not be reached with 
any other assay format than high-content imaging. A stable HEK293 cell line was generated 
overexpressing the protein of interest fused to the HA tag. The detection was based on 
immunostaining with anti HA antibody followed by a secondary antibody requiring several 
washing steps. Since HEK293 cells are sensitive to repeated washing steps it was necessary 
to use poly-D-lysine coated imaging plates which are commercially available.  
In this example high-resolution images were needed for the sophisticated image analysis 
algorithm based on spot detection. Variable spot size with variable intensity was analyzed 
in the cytoplasmic area which was identified by GFP fluorescence in the cytoplasm. 
Therefore three colours were imaged with the Opera QEHS, and in order to reach sufficient 
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quality required for HTS two images were acquired per well using a 20x objective. Imaging 
and simultaneous image analysis summed up to an imaging time of 90 min per plate. 
According to the setup of the automated plate preparation system, we were able to process 
>120 x 1536 well plates per week, however, due to the long imaging time, the throughput 
was limited to 90 plates per weeks.  
 
 
Fig. 7. Protein aggregation in HEK293 cells overexpressing protein of interest tagged with 
HA-tag (green), nuclear stain Hoechst 33342 (red). A) untreated, B) cells treated with control 
compound. For better visualization the channel for GFP is not shown and the colours have 
been changed. 
4.2 Medium-throughput screen for granularity 
The possibility to quantitatively analyse sub-cellular compartments within the cell is one of 
the advantages of HCS which makes it for certain projects the unique technique for hit 
identification. In this example project, the detection of both red and green granules in the 
cytoplasm of human bladder epithelial cells was aimed for (Fig. 8). For good resolution a 
20x objective was required and therefore the use of the laser scanning instrument Acumen 
was not considered for this project. Long incubation times of the cells made the 1536-well 
format not suitable and reduced the amount of compounds to be screened to medium 
throughput.  
384-well plates were measured both on the confocal imager Opera QEHS and on the lamp-
based imager IN Cell Analyzer 2000 in order to compare image quality and imaging time.  
Using the 20x objective the image size of Opera images is 430 x 345 µm, whereas the IN Cell 
Analyzer 2000 has a large field of view camera which results in 760 x 760 µm images. Thus, 
for imaging the same number of cells two images per well and almost double the imaging 
time was required with Opera compared to IN Cell Analyzer 2000. Lowering the number of 
cells imaged had a negative impact on assay quality. Therefore, in this particular assay the 
imaging time with Opera was 40 min longer per plate already taking into account the ability 
to acquire images on two channels simultaneously (Table 1).  
4.3 Measurement of fluorescence intensity  
In most projects high-resolution images are needed for sub-cellular analysis, but in some 
projects low-resolution images provide adequate results and assay quality. This is especially 
true for assays where fluorescence intensity is the main readout. In a high-throughput 
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screening campaign we were looking for compounds inhibiting post-translational 
modification of a protein localized in the nucleus of a prostate cancer cell line.  We 
monitored two different post-translational modifications simultaneously using antibody 
staining and measuring the fluorescence intensity in the nuclear region. The images taken 
with Opera QEHS are shown in Fig. 9. The resolution requirements of fluorescence intensity 
measurement are in general not very high, therefore imaging with the Acumen was 
considered for this project.  
Opera and Acumen provided qualitatively comparable results in 1536-well format in terms 
of signal to baseline ratio and Z’ values, with the Acumen being much faster with 30 min 
versus 90 min imaging time with Opera (Table 2). In this specific project the cells needed to 
be plated at low density, therefore the lower resolution of the Acumen was counterbalanced 
by the improved statistical quality due to the ability to read the whole well by Acumen (Fig 
10).   
Primary hit finding was performed using the Acumen whereas the follow-up in 
concentration-response-curves was done with Opera QEHS to allow the possibility of 
checking the images for specific compound effects. The reduced imaging time as well as the 
reduced amount of data storage of the Acumen is an advantage for high-throughput 
screening in cases where lower resolution is acceptable.  
 
 
Fig. 8. Granule detection in RT112 cells (human bladder epithelial cells) stably expressing 
GFP (green) and mCherry fusion proteins (red). Nuclei are stained with Hoechst 33342 
(blue). A) untreated, B) cells treated with control compound. 
 
 
Table 1. Overview of imaging time of Opera and IN Cell 2000 for granularity measurement  
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Fig. 9. Images for fluorescence intensity measurement acquired with Opera. DU145 cells 
(human prostate cancer cells) stained with Antibody B (green), nuclear stain (blue).  For 
better visualization only two colours are shown in the overlay images. A) untreated, B) cells 
treated with control compound. 
 
 
 
Fig. 10. Fluorescence intensity measurement with Acumen. DU145 cells (human prostate 
cancer cells) stained with nuclear stain (blue),  antibody A (green), antibody B (red).  
 
 
 
Table 2. Overview of imaging time of Opera and Acumen for fluorescence intensity 
measurement. 
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4.4 Analysis of nuclear translocation 
Nuclear translocation assays can deliver functional readouts without the side effect of 
generating many false positives as other conventional assay formats might comprise.  
Having the advantage of observing the compounds effect on the cells, we decided to screen 
for small molecules inhibiting the translocation of a protein to the nucleus in U-2 OS cells 
overexpressing a GFP fusion protein. Since both Opera and Acumen are able to measure 
nuclear translocation, both were compared for quality and throughput.  The assay was quite 
robust and did not require a very high resolution for the image analysis. Both instruments 
were able to provide good assay quality in 1536-well format. The plate measurement time 
was 25 min both with Acumen and with Opera.  A 10x objective was used on the Opera and 
the images were acquired on two channels simultaneously. The applied image analysis on 
Opera needed longer than the effective imaging time and would have reduced the 
throughput. However, after streamlining the algorithm, the time of physical imaging and 
image analysis matched.  
Since the confocal images by Opera provide more information on the samples than a plate 
scanner, the Opera was chosen as the screening instrument for that particular project.   
 
 
Fig. 11. Translocation of GFP-fusion protein from nuclear region upon small molecule 
addition. Image analysis is based on the fluorescence intensity in the nuclear area compared 
to cytoplasm. U-2 OS cells overexpressing GFP fusion protein (green), nuclear stain DRAQ5 
(red). A) untreated, B) cells treated with control compound. 
4.5 Overview of selected imaging projects 
Four different examples are described above with varying requirements for resolution and 
therefore different choices of imagers for screening. Every assay is optimized for lowest 
imaging time and highest throughput without loss of quality. Imaging time can vary 
strongly between 25 to 90 min per 1536 well plate as shown in Table 3.  
However, optimizing the imaging time alone is often not sufficient to run a HCS in high 
throughput; also the immunostaining procedure can be a bottleneck. Antibody staining is 
much more time consuming than working with GFP fusion proteins since several washing 
steps are required. To speed up and simplify the staining process the fixative can be added 
directly to the cell medium, blocking buffer and permeabilization reagent can be combined 
in one step as well as the nuclear stain added together with the secondary antibody.  
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Project Imager Plate format Cells
No of 
compounds 
screened
Colours Images/well Objective
Imaging 
time/plate 
(min)
Protein aggregation Opera 1536 Hek293 >1 mio 3 2 20 x 100
Fluorescence 
intensity
Opera 1536 HEK293 550k 2 2 20 x 55
Nuclear 
translocation
Opera 1536 U-2 OS >1 mio 2 1 10 x 25
Fluorescence 
intensity
Acumen 1536 DU145 >1 mio 3 whole well Ca 10x 30
Protein aggregation Opera 384 U-2 OS 25k 2 4 20 x 30*
1 20 x 60*Granule detection IN Cell 2000 384 RT112 20k 3
 
Table 3. List of high-throughput assays with different requirements and the effect on the 
imaging time. * The imaging time needs to be multiplied with 4 in order to compare with 
imaging of 1536-well plates. 
4.6 Technical issues in high-throughput HCS 
The time consuming plate preparation process in addition to imaging time (up to several 
days) can result in delayed quality control measures to detect errors in cell plating or 
compound distribution.  This can be a major issue if undetected failures of batch preparation 
can only be reported back after a week.  
Since the imaging can be of long duration (90 min or more per plate) the 1536-well plates 
need to be stored in an incubator at 4 °C to prevent evaporation. Nevertheless, before 
imaging an intermediate step should be calculated to accommodate the plates to room 
temperature to avoid condensation, therefore we have introduced a 30 min incubation time 
at room temperature before imaging. Storing fixed and stained plates at 4 °C will allow a 
later use of the plates for imaging. This decoupled process is beneficial in case of a failure of 
the plate preparation systems. We observed that although antibacterial agents were added, 
contaminations can occur with plate storage for longer than two weeks.  
Due to small volumes of reagents and the use of common, frequently opened incubators we 
experienced strong edge effects on 1536-well plates. We were able to compensate that 
partially with higher volumes of medium or buffer during the incubation steps and using 
dedicated incubators that are less frequently opened. With a specifically designed 1536-well 
plate comprising a tightly closing lid (labyrinth lid) evaporation can be mitigated (Pfeifer 
and Scheel, 2009). In addition, the performance of the plate washers and dispensers needs to 
be monitored continuously since the washing and dispensing steps are essential for a good 
performance.  The 1536-well dispensing or washing devices have tiny pins which are prone 
to clogging. Therefore a regular cleaning procedure with detergent, water and ethanol after 
every use is necessary which leads to a limit in unattended use of the automation systems. 
Furthermore, working with 1536-well plates often requires shaking to distribute the added 
reagents evenly. We have added a high-speed shaking step after each reagent addition to 
our protocol.  
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5. HCS in small-scale analysis 
In contrast to high-throughput assays, where automation-friendly assays and high speed of 
imaging and image analysis are of utmost importance, in small-scale analysis more complex 
assay formats are possible. Assay protocols requiring manual or semi-manual steps can be 
used and precious primary cells, such as neurons, even co-cultures can be used (Anderl et 
al., 2009). The ability to use primary cells and analyze endogenous proteins can be of great 
benefit which is enabled by antibody labelling and the sensitivity of confocal imaging. Also 
several components can be stained in parallel, and to improve the statistical quality of the 
assay, several images on different channels can be acquired when speed is not the most 
critical factor. A thorough image and data analysis for also non-expected features can be 
performed to obtain all possible information from the cells after different treatments.   
We have used low and medium-throughput high-content assays to analyze cellular 
neurotoxicity, neurite outgrowth and neuronal survival. Using primary rat cerebellar 
granule neurons (CGNs) we developed an imaging assay that has been used in medium 
throughput to study neurotoxicity (Götte et al., 2010) and neurite outgrowth-promoting 
activity of low-molecular weight compounds (see below) or proteins (Yan et al,. 2009). The 
rat cerebellar granule cells can be prepared from a litter of 7-8 pups in 3 h, and the amount 
of cells obtained allows analysis of 2500 samples in 96-well format and 12.500 samples in 
384-well format. The cells can be frozen without loss of viability or ability to grow neurites. 
Thereby assays with even higher throughput are possible. The intactness of the neuritic 
network in a high-content assay proved out to be a sensitive measure for cellular 
neurotoxicity, revealing compound toxicity that was not detected in non-HCS assays or in 
neuroblastoma cells (Götte et al., 2010). The HCS assay was used to analyze cellular 
neurotoxicity of compounds whose targets were expressed in the brain. 
We have also used the CGNs to study neurite outgrowth in small-scale assays. The neurite 
outgrowth assay was first developed and validated using the brain-derived neurotrophic 
factor (BDNF) whose receptor, TrkB, is expressed in the developing CGNs (Segal et al., 
1995). Images were acquired with IN Cell Analyzer 3000 and image analysis revealed that 
BDNF enhanced neurite outgrowth dose-dependently. Additional analysis of the images 
with a third party software, Neurite Analysis module of HCA-Vision, that is specifically 
designed to analyze neuronal cultures, revealed that the enhanced neurite outgrowth was 
rather due to increased branching and increased number of neurites per neuron than 
increased length of the neurites (Wang et al., 2010). Such detailed information of neuronal 
morphology can be obtained only from an imaging assay. 
We tested the ability of other neurotrophins to promote neurite outgrowth or neuronal 
survival. Therefore, the CGNs were incubated for 3 days with the neurotrophins, then fixed 
and stained with the nuclear marker Hoechst 33342 and anti ┚-tubulin III antibody to 
specifically label neurons (Lewis and Cowan, 1988). Images were acquired with IN Cell 
Analyzer 3000 and analyzed with IN Cell 3000 Neurite Outgrowth module for various 
readouts in respect to neurite area and length (Fig 12). BDNF (10 ng/ml) served as a positive 
control.  
Image analysis revealed that the TrkB ligands, BDNF and NT-4, increased the total number 
of cells in the culture significantly, suggesting that they have a cell survival-promoting effect 
(Fig. 12).  NT-4 and BDNF enhanced also neurite outgrowth significantly, as seen by the 
increase of neurite length and neurite area per cell. NT-4 was the most potent neurotrophin 
enhancing neurite number and branching as analyzed additionally with the HCA-Vision 
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software.  NT-3 enhanced neurite outgrowth modestly and only at high concentrations. The 
preferred receptor for NT-3 is TrkC which is expressed in the CGNs at a lower level than 
TrkB (Segal et al., 1995), and accordingly, NT-3 had a slight positive effect on cell survival 
and neurite outgrowth. NT-3 also enhanced the number of neurites at high concentration 
(Fig. 12) whereas NGF had no effect on either cell survival or neurite outgrowth. This is in 
accordance with other published data (Courtney et al., 1997; Nonomura et al., 1996), and our 
own quantitative RT-PCR results indicating very low expression of the NGF receptor, TrkA 
in the CGNs (not shown). Thus, the high-content assay was able to reveal expected effects of 
known neurotrophins validating the assay setup. 
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Fig. 12. Effect of neurotrophins NT-4, NT-3 and NGF on cell survival and neurite outgrowth.  
CGNs from 7 day old rats were incubated with the neurotrophins for 3 days before fixation 
and staining. Average and standard deviation of triplicate samples are shown. Area and 
length of neurites are in pixels; pixel size is 0.6 µm. Statistical significance in comparison to 
DMSO control; ***, p <0.001; ** p<0.01; * p<0.05 in Student' two-tailed paired t-test. 
The goal was to identify low-molecular weight compounds mimicking the effect of 
neurotrophins. Several antidepressants have been reported to activate the TrkB pathway in 
vivo (Rantamäki et al., 2007). Therefore, we were interested to test the effect of selected 
antidepressants on neurite outgrowth of the CGNs expressing TrkB. Three of the nine tested 
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antidepressants enhanced neuronal survival and/or neurite outgrowth significantly. In 
addition, image analysis was able to reveal differences in the effects among the three active 
drugs.  
Citalopram induced the most pronounced, concentration-dependent neurite outgrowth by 
enhancing significantly cell survival and the percentage of neuronal cells in the culture (Fig. 
13). Neurite outgrowth and percentage of neurons were increased by imipramine up to 1 
M (Fig. 13.), however, at higher concentration neurite outgrowth was reduced, which 
could indicate cytotoxicity. Fluoxetine did not enhance cell survival but it enhanced neurite 
outgrowth at low concentrations. At high concentration (10 µM) fluoxetine was toxic 
reducing total cell number and percentage of neuronal cells and inhibiting neurite 
outgrowth almost completely.  
The advantage of HCS over assays that analyze total amounts of markers, such as ┚-tubulin III 
or neurofilament, is that the effect on cell survival and neurite outgrowth can be distinguished. 
The enhancing effect of fluoxetine on neurite outgrowth, for example, would probably remain 
undetected in an assay analyzing merely the total amount of ┚-tubulin due to the fact that 
fluoxetine slightly reduced the cell number as compared to the DMSO control. 
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Fig. 13. Effect of fluoxetine, imipramine and citalopram on cell survival and neurite 
outgrowth. Average and standard deviation of triplicate samples are shown. The 
concentration of BDNF was 10 ng/ml. The concentrations of the antidepressants are in µM. 
Area and length of neurites are in pixels; pixel size is 0.6 µm. Statistical significance in 
comparison to DMSO control; ***, p <0.001; ** p<0.01; * p<0.05 in Student' two-tailed paired 
t-test. 
In small-scale experiments, such as the study of the effect of neurotrophic factors and the 
antidepressants on neurite outgrowth, an extra colour can be afforded to reveal additional 
effects of the drugs. In our example, the CGN samples were stained additionally with an 
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antibody against TrkB which uncovered an interesting, unexpected phenomenon. TrkB was 
found to localize to the cell bodies and neurites. TrkB was also found in the tips of the 
growing neurites but only when the cells were cultivated in the absence of a TrkB ligand. 
The presence of the TrkB ligands BDNF or NT-4, caused disappearance of the TrkB receptor 
from the tips (Fig. 14).  
 
 
Fig. 14. TrkB ligands and citalopram reduce localization of TrkB to the tips of the neurites. 
Rat CGNs from 7-8 day old pups were incubated for 3 days with the neurotrophins, DMSO 
or citalopram, then fixed, stained and images were acquired with IN Cell Analyzer 3000. 
Red, anti TrkB; green, anti ┚-tubulin III; blue, nuclei. 
In order to quantify TrkB specifically in the tips of the neurites, the neurites were first traced 
semi-manually with the help of the -tubulin III staining and using the Imaris® software 
(Bitplane AG, Zurich, Switzerland). Then the tips were marked as regions of interest (Fig. 
15), and the area and intensity of TrkB staining in the marked tips were calculated with a 
customized MATLAB code. The quantification of TrkB in the tips of the neurites confirmed 
the visual observation that indeed the TrkB ligands BDNF and NT-4 reduced TrkB in the 
tips, whereas NGF did not. Surprisingly, also one of the antidepressants, citalopram, caused 
disappearance of TrkB from tips of the neurites. Whether this is a direct effect of citalopram 
or whether it stimulates secretion of BDNF which then causes the internalization of TrkB, 
remains to be studied. Anyhow, this is an example that an additional staining and careful 
image analysis can reveal unexpected effects of the compounds, and in this special case can 
help to reveal the mode of action of the active compounds.  
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Fig. 15. Quantification of TrkB in the tips of the neurites. A, Image with regions of interest 
(red) where intensity and area of TrkB staining was measured. Green, ┚-tubulin staining; 
blue, nuclei stained with Hoechst 33342. B, intensity of TrkB staining in the tips as analyzed 
with a MATLAB code. For each condition 29-62 neurites were analyzed. 
6. Outlook 
The HCS field is developing in two directions. On one hand more sophisticated assays are 
being developed and more complex biological systems are being exploited, such as stem 
cells (embryonic, adult, IPS), primary cells, co-cultures, and even tissues and worms like C. 
elegans are quantitatively analyzed. This development is being enabled by improved image 
analysis software packages for co-cultures or label-free samples.  
On the other hand HCS is rendered possible for real high-throughput screening in primary 
hit finding campaigns through instruments with 1536-well capabilities combining high 
imaging speed and resolution.  Robust assays required for primary hit finding are being 
developed and sophisticated image analysis packages allow fast, on-the-fly image analysis 
for real time quality control.  
Novel imagers with adjustable confocality and large field of view, which have recently 
become available, will increase the flexibility and throughput of high-content assays. Hard- 
and software for sub-cellular imaging are developing for more modular use of the 
equipment to allow increased diversity of applications, including live-cell imaging with 
environmental control and even fast kinetics with reagent additions. The analysis of the 
generated multiparametric data is further emerging and different ways to analyze the vast 
HCS data are being exploited, with an increasing number of available tools for data 
visualization.  
7. Summary 
HCS is an established but still evolving technology in drug discovery. HCS enables in 
primary screening and compound profiling novel assay formats which were earlier 
impossible in higher throughput. In addition, sub-cellular imaging is able to deliver more 
content through multi-parametric data analysis of shape, size, and area in addition to the 
target-specific fluorescence readouts. There are biological requirements for successful HCS 
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campaigns including well separated cells as well as dedicated algorithms for the respective 
image analysis. HCS in high throughput requires automated platforms for sample 
preparation, high-speed imagers and data analysis software with a dedicated IT 
infrastructure to manage and mine the wealth of data produced. Primary hit finding can be 
performed in medium to high throughput with a variety of biological readouts based on 
sub-cellular imaging, including protein aggregation, granularity detection or translocation 
events. In lower throughput follow-up assays, sub-cellular imaging can be applied to 
thoroughly analyze compound effects on primary cells and to reveal additional, unexpected 
effects. At this point it is too early to evaluate the impact of HCS in novel drugs, whether 
they are improved in having less undesired side-effects, or developed faster, or whether the 
attrition rate at late phases would be decreased. 
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a growing urgency to identify and develop more effective, efficient, and expedient ways to bring safe and
effective products to the market. The drug discovery and development process relies on the utilization of
relevant and robust tools, methods, models, and validated biomarkers that are predictive of clinical effects in
terms of diagnosis, prevention, therapy, and prognosis. There is a growing emphasis on translational
research, a bidirectional bench to the bedside approach, in an effort to improve the process efficiency and the
need for further innovations. The authors in the book discuss the current and evolving state of drug discovery
and development.
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